Transaction in Own Shares
Rhea-AI Summary
Shell (SHEL) purchased shares for cancellation on 30 December 2025 as part of its ongoing buy-back programme announced 30 October 2025. Purchases by trading venue included 931,618 shares on LSE at a VWAP of £27.3075 and 932,279 shares on XAMS at a VWAP of €31.3647, totalling 1,863,897 shares cancelled.
Merrill Lynch International is executing the programme independently for the period 30 October 2025–30 January 2026. The programme is conducted under Chapter 9 UK Listing Rules and EU/UK MAR rules.
Positive
- 1,863,897 shares purchased and cancelled on 30 December 2025
- LSE VWAP £27.3075 and XAMS VWAP €31.3647 recorded
- Buy-back executed under existing programme through 30 January 2026
Negative
- None.
News Market Reaction – SHEL
On the day this news was published, SHEL gained 0.97%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Energy peers showed mixed, low-magnitude moves (e.g., XOM +0.32%, BP -0.45%), suggesting today’s buy-back disclosure for SHEL is more company-specific than part of a broad sector swing.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 24 | Share buy-back | Positive | -0.3% | Disclosure of 24 Dec buy-back trades on LSE and XAMS for cancellation. |
| Dec 24 | PDMR shareholding | Neutral | -0.3% | Dividend share acquisitions by senior management across multiple venues. |
| Dec 23 | Share buy-back | Positive | +0.7% | 1.46M shares bought back and cancelled across LSE and XAMS. |
| Dec 22 | Share buy-back | Positive | +0.8% | 1.46M shares repurchased under ongoing October 2025 programme. |
| Dec 19 | Share buy-back | Positive | +1.0% | 1.97M shares bought back for cancellation on 19 Dec 2025. |
Recent buy-back announcements often coincided with modest positive next-day moves, with one notable divergence on similar news.
Over the past weeks, Shell reported multiple buy-back executions, cancelling between ~1.4M–2.0M shares per disclosed day across LSE and XAMS, with VWAPs mostly around £26.8–27.1 and €30.6–31.1. A separate December filing detailed dividend-related PDMR share acquisitions. These updates, together with today’s transaction in own shares, underline a consistent capital return pattern under programmes running through 30 January 2026 and conducted under UK/EU MAR frameworks.
Market Pulse Summary
This announcement details another day of buy-backs under Shell’s existing programme, with purchases on the LSE and XAMS at VWAPs of GBP 27.3075 and EUR 31.3647, respectively. It continues a sequence of December disclosures where millions of shares were cancelled under MAR-compliant frameworks. Investors may watch the cumulative reduction in share count, adherence to the programme window through 30 January 2026, and any future adjustments to capital return plans.
Key Terms
on- and off-market financial
UK Listing Rules regulatory
EU MAR regulatory
UK MAR regulatory
AI-generated analysis. Not financial advice.
Transaction in Own Shares
30 December, 2025
• • • • • • • • • • • • • • • •
Shell plc (the ‘Company’) announces that on 30 December, 2025 it purchased the following number of Shares for cancellation.
Aggregated information on Shares purchased according to trading venue:
| Date of purchase | Number of Shares purchased | Highest price paid | Lowest price paid | Volume weighted average price paid per share | Venue | Currency |
| 30/12/2025 | 931,618 | 27.4050 | 27.0900 | 27.3075 | LSE | GBP |
| 30/12/2025 | - | - | - | - | Chi-X (CXE) | GBP |
| 30/12/2025 | - | - | - | - | BATS (BXE) | GBP |
| 30/12/2025 | 932,279 | 31.4600 | 31.1850 | 31.3647 | XAMS | EUR |
| 30/12/2025 | - | - | - | - | CBOE DXE | EUR |
| 30/12/2025 | - | - | - | - | TQEX | EUR |
These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 30 October 2025.
In respect of this programme, Merrill Lynch International will make trading decisions in relation to the securities independently of the Company for a period from 30 October 2025 up to and including 30 January 2026.
The on-market limb will be effected within certain pre-set parameters and in accordance with the Company’s general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Company’s general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 9 of the UK Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (“EU MAR”) and EU MAR as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (“UK MAR”) and the Commission Delegated Regulation (EU) 2016/1052 (the “EU MAR Delegated Regulation”) and the EU MAR Delegated Regulation as “onshored” into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time.
In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Merrill Lynch International on behalf of the Company as a part of the buy-back programme is detailed below.
Enquiries
Media: International +44 (0) 207 934 5550; U.S. and Canada: https://www.shell.us/about-us/news-and-insights/media/submit-an-inquiry.html
Attachment
